66 related articles for article (PubMed ID: 18336616)
21. Genetic alterations in the PI3K pathway in prostate cancer.
Sun X; Huang J; Homma T; Kita D; Klocker H; Schafer G; Boyle P; Ohgaki H
Anticancer Res; 2009 May; 29(5):1739-43. PubMed ID: 19443396
[TBL] [Abstract][Full Text] [Related]
22. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.
Smith MJ; Culhane AC; Killeen S; Kelly MA; Wang JH; Cotter TG; Redmond HP
Ann Surg Oncol; 2008 Oct; 15(10):2954-64. PubMed ID: 18622646
[TBL] [Abstract][Full Text] [Related]
24. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway.
Contreras-Paredes A; De la Cruz-Hernández E; Martínez-Ramírez I; Dueñas-González A; Lizano M
Virology; 2009 Jan; 383(1):78-85. PubMed ID: 19007961
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A
Clin Cancer Res; 2008 May; 14(9):2673-80. PubMed ID: 18451231
[TBL] [Abstract][Full Text] [Related]
26. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
Marsh J; Mukherjee P; Seyfried TN
Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
28. Marked gene transcript level alterations occur early during radical prostatectomy.
Schlomm T; Näkel E; Lübke A; Buness A; Chun FK; Steuber T; Graefen M; Simon R; Sauter G; Poustka A; Huland H; Erbersdobler A; Sültmann H; Hellwinkel OJ
Eur Urol; 2008 Feb; 53(2):333-44. PubMed ID: 17448597
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer: mutations in a signalling pathway.
Parsons DW; Wang TL; Samuels Y; Bardelli A; Cummins JM; DeLong L; Silliman N; Ptak J; Szabo S; Willson JK; Markowitz S; Kinzler KW; Vogelstein B; Lengauer C; Velculescu VE
Nature; 2005 Aug; 436(7052):792. PubMed ID: 16094359
[TBL] [Abstract][Full Text] [Related]
30. Overgrowth syndromes: is dysfunctional PI3-kinase signalling a unifying mechanism?
Barker KT; Houlston RS
Eur J Hum Genet; 2003 Sep; 11(9):665-70. PubMed ID: 12939652
[TBL] [Abstract][Full Text] [Related]
31. An activating mutation in AKT1 in human prostate cancer.
Boormans JL; Hermans KG; van Leenders GJ; Trapman J; Verhagen PC
Int J Cancer; 2008 Dec; 123(11):2725-6. PubMed ID: 18798258
[No Abstract] [Full Text] [Related]
32. New bigenic mouse model increases the understanding of genetic synergism in the progression of prostate cancer.
Polman DJ; Price DK; Figg WD
Cancer Biol Ther; 2015; 16(12):1702-3. PubMed ID: 26552331
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase in tumour viruses.
Nature; 1971 Sep; 233(5317):236. PubMed ID: 16063309
[No Abstract] [Full Text] [Related]
34. PHLPP1 is a metastasis suppressor in melanoma.
Dai M; Yu Y
Aging (Albany NY); 2018 Sep; 10(9):2214-2215. PubMed ID: 30187888
[No Abstract] [Full Text] [Related]
35. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
36. FANCI is a negative regulator of Akt activation.
Zhang X; Lu X; Akhter S; Georgescu MM; Legerski RJ
Cell Cycle; 2016; 15(8):1134-43. PubMed ID: 27097374
[TBL] [Abstract][Full Text] [Related]
37. Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).
Crotty TM; Nakano T; Stafforini DM; Topham MK
J Biol Chem; 2013 Jan; 288(3):1439-47. PubMed ID: 23184957
[TBL] [Abstract][Full Text] [Related]
38. Suppression of survival signalling pathways by the phosphatase PHLPP.
O'Neill AK; Niederst MJ; Newton AC
FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
[TBL] [Abstract][Full Text] [Related]
39. Guide to virtual screening: application to the Akt phosphatase PHLPP.
Sinko W; Sierecki E; de Oliveira CA; McCammon JA
Methods Mol Biol; 2012; 819():561-73. PubMed ID: 22183558
[TBL] [Abstract][Full Text] [Related]
40. New strategies for Alzheimer's disease and cognitive impairment.
Maiese K; Chong ZZ; Hou J; Shang YC
Oxid Med Cell Longev; 2009; 2(5):279-89. PubMed ID: 20716915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
